Pasture Holdings UUK

SGD 0.075 +0.00% +0.00 Updated 13 Nov 2026, 17:16 SGT

Company profile

The business, the people and the ownership behind Pasture Holdings.

Investor relations ↗Official company website

Business overview

About the company

Pasture Holdings develops and distributes pharmaceutical and healthcare products. Founded in Singapore, the group serves customers across international healthcare markets.

Annual Report 2026 ↗ Reviewed 2026-10-23 · Source dated 2026-10-07. PDF p. 2

Listed security

Company & listing

Full Company Name: PASTURE HOLDINGS LTD.
Trading Currency: SGD
Website: www.pasturegroup.com
Listing: Listed on 9 June 2023 on CATALIST
ISIN Code: SGXE54661850

Board & management

Leadership

PDF p. 13

Soong Chin Kum Jonathan Lloyd

Executive Chairman and Chief Executive Officer

Board of Directors and CEO

Prashanth Palepu

Non-Executive and Non-Independent Director

Board of Directors

Lim Jit Soon

Non-Executive and Lead Independent Director

Board of Directors

Teo Kwee Yee

Non-Executive and Independent Director

Board of Directors

Low Su-Shing

Non-Executive and Independent Director

Board of Directors

Claire Soong Jia Li

Alternate Director to Soong Chin Kum Jonathan Lloyd

Board of Directors

Roles listed in Annual Report 2026; current appointments are not independently verified.

Holdings

Ownership

As reported at 2026-09-14 · PDF p. 114

Plutus Star Holding Pte. Ltd.

Direct interest 38,080,000 shares (28.85%); deemed interest 0 (0.00%)

Direct

PMI Holdings Pte. Ltd.

Direct interest 73,920,000 shares (56.00%); deemed interest 0 (0.00%)

Direct

Srinivasa Gopal Palepu(1)

Deemed interest 38,080,000 shares (28.85%); direct 0 (0.00%)

Deemed

Pranay Palepu(2)

Deemed interest 38,080,000 shares (28.85%); direct 0 (0.00%)

Deemed

Prashanth Palepu(3)

Deemed interest 38,080,000 shares (28.85%); direct 0 (0.00%)

Deemed

Soong Chin Kum Jonathan Lloyd(4)

Deemed interest 73,920,000 shares (56.00%); direct 0 (0.00%)

Deemed

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 22 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-09-14 · PDF p. 113

Registered holder	Interest	Source
PMI HOLDINGS PTE. LTD.	73,920,000 shares (56.00%)	PDF p. 1132026-09-14
PLUTUS STAR HOLDING PTE. LTD.	38,080,000 shares (28.85%)	PDF p. 1132026-09-14
MAYBANK SECURITIES PTE. LTD.	5,200,000 shares (3.94%)	PDF p. 1132026-09-14
CHNG NAI WEE	4,000,000 shares (3.03%)	PDF p. 1132026-09-14
TAY ENG HSEON	3,760,000 shares (2.85%)	PDF p. 1132026-09-14
UOB KAY HIAN PTE LTD	1,759,900 shares (1.33%)	PDF p. 1132026-09-14
ANG MENG HAI MARKUS DAVID	1,200,000 shares (0.91%)	PDF p. 1132026-09-14
WONG HENG YIEW	400,000 shares (0.30%)	PDF p. 1132026-09-14
MOOMOO FINANCIAL SINGAPORE PTE. LTD.	375,300 shares (0.28%)	PDF p. 1132026-09-14
ABN AMRO CLEARING BANK N.V.	277,300 shares (0.21%)	PDF p. 1132026-09-14
LONG JEE JONG	205,800 shares (0.16%)	PDF p. 1132026-09-14
CGS INTERNATIONAL SECURITIES SINGAPORE PTE. LTD.	180,000 shares (0.14%)	PDF p. 1132026-09-14
BERNARDO WANGSA	160,000 shares (0.12%)	PDF p. 1132026-09-14
CAROLINA ROSALINDA LAU	160,000 shares (0.12%)	PDF p. 1132026-09-14
CHRISTIE KERK LAY TIN	160,000 shares (0.12%)	PDF p. 1132026-09-14
HENG TUNG LAN	160,000 shares (0.12%)	PDF p. 1132026-09-14
HO PEI JIA ANNA	160,000 shares (0.12%)	PDF p. 1132026-09-14
KOH KEE LIAN LILIAN	160,000 shares (0.12%)	PDF p. 1132026-09-14
LEE KIAM LENG DESMOND (LI JIANLONG DESMOND)	160,000 shares (0.12%)	PDF p. 1132026-09-14
LUCA SELDON@LUCA MORETTI SELDON	160,000 shares (0.12%)	PDF p. 1132026-09-14
TAN SOCK HUA (CHEN SHU HUA)	160,000 shares (0.12%)	PDF p. 1132026-09-14
YAP BOH WEI	160,000 shares (0.12%)	PDF p. 1132026-09-14

Group structure

Main operating subsidiaries

PDF p. 96

Company	Market	Ownership interest
Pasture Pharma Pte LtdSubsidiary, 2026 (2025: 100%)	100%; Singapore; wholesale of medicinal and pharmaceutical products (western) and wholesale of medical, professional, scientific and precision equipment
Pasture PharmaHub Pte. Ltd.Subsidiary, 2026 (2025: 100%)	100%; Singapore; wholesale of medicinal and pharmaceutical products (western) and wholesale of medical, professional, scientific and precision equipment
Pacific Biosciences Pte LtdSubsidiary, 2026 (2025: 100%)	100%; Singapore; wholesale of medicinal and pharmaceutical products (western) and veterinary activities

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Item	Value	Period / scope	Source
Mr. Tan Xi Yi	Chief Operating Officer	Executive Team	PDF p. 15
Mr. Lee Quang Loong	Chief Financial Officer	Executive Team	PDF p. 15
Ms. Ho Huey-Yi	Chief Pharmacist	Executive Team	PDF p. 15
Claire Soong Jia Li	Alternate Director to Soong Chin Kum Jonathan Lloyd	Corporate Information roster	PDF p. 13
Peck Jen Jen	Company Secretary	Corporate Information	PDF p. 13

Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

Item	Value	Period / scope	Source
Number of issued shares	132,000,000 shares	As at 14 September 2026 · As at 2026-09-14	PDF p. 113
Class of shares	Ordinary Shares	As at 14 September 2026 · As at 2026-09-14	PDF p. 113
Voting rights	One vote per share	As at 14 September 2026 · As at 2026-09-14	PDF p. 113

Treasury shares

Item	Value	Period / scope	Source
Number of treasury shares	Nil	As at 14 September 2026 · As at 2026-09-14	PDF p. 113
Number of subsidiary holdings	Nil	As at 14 September 2026 · As at 2026-09-14	PDF p. 113

Shareholding distribution

Item	Value	Period / scope	Source
TOTAL	72 shareholders	Total shareholders, as at 14 September 2026 · As at 2026-09-14	PDF p. 113
1 - 99	– shareholders; 0.00%; – shares; 0.00%	Size band 1 - 99, as at 14 September 2026 · As at 2026-09-14	PDF p. 113
100 - 1,000	11 shareholders; 15.28%; 4,600 shares; 0.00%	Size band 100 - 1,000, as at 14 September 2026 · As at 2026-09-14	PDF p. 113
1,001 - 10,000	21 shareholders; 29.17%; 130,200 shares; 0.10%	Size band 1,001 - 10,000, as at 14 September 2026 · As at 2026-09-14	PDF p. 113
10,001 - 1,000,000	33 shareholders; 45.83%; 3,945,300 shares; 2.99%	Size band 10,001 - 1,000,000, as at 14 September 2026 · As at 2026-09-14	PDF p. 113
1,000,001 AND ABOVE	7 shareholders; 9.72%; 127,919,900 shares; 96.91%	Size band 1,000,001 and above, as at 14 September 2026 · As at 2026-09-14	PDF p. 113

Free float

Item	Value	Period / scope	Source
SHAREHOLDINGS HELD IN THE HANDS OF THE PUBLIC	approximately 15.15%	As at 14 September 2026 · As at 2026-09-14	PDF p. 114
SHAREHOLDINGS HELD IN THE HANDS OF THE PUBLIC	Rule 723 of the Catalist Rules is complied with.	As at 14 September 2026 · As at 2026-09-14	PDF p. 114

Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

Item	Value	Period / scope	Source
Interested person transaction	There was no interested person transaction (“IPT”) which was more than S$100,000 entered into during FY2026.	Group, FY2026	PDF p. 64
Purchases (a) (b)	74 US$'000	Group, 2026 (comparative 2025: 1)	PDF p. 84
Sales (b)	189 US$'000	Group, 2026 (comparative 2025: –)	PDF p. 84
Salaries and bonuses	877 US$'000	Group, 2026 (comparative 2025: 755)	PDF p. 84

Director remuneration

Item	Value	Period / scope	Source
Remuneration of directors of the company	406 US$'000	Group, 2026 (comparative 2025: 330)	PDF p. 84
Soong Chin Kum Jonathan Lloyd	416 S$'000	Company directors, FY2026; 100% fixed salary	PDF p. 56
Prashanth Palepu	36 S$'000	Company directors, FY2026; 100% directors' fees	PDF p. 56
Lim Jit Soon	39 S$'000	Company directors, FY2026; 100% directors' fees	PDF p. 56
Teo Kwee Yee	38 S$'000	Company directors, FY2026; 100% directors' fees	PDF p. 56
Low Su-Shing	38 S$'000	Company directors, FY2026; 100% directors' fees	PDF p. 56

Employees

Item	Value	Period / scope	Source
Number of Employees	6 17 6 19	Group, FY2026 Male 6, Female 17; FY2025 Male 6, Female 19	PDF p. 30

Contingent liabilities

Item	Value	Period / scope	Source
Bank loan B	A corporate guarantee by the company.	Company guarantee for Group bank loan A, Note 23 · As at 2026-06-30	PDF p. 104

Subsequent events

Item	Value	Period / scope	Source
Subsequent developments to reporting date	There are no significant developments subsequent to the release of the group’s and the company’s preliminary financial statements	Group and company	PDF p. 68

Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.

Source: Annual Report 2026 ↗

Corporate information

Registration & contacts

Incorporated In: SINGAPORE
Incorporated On: 03 Nov 2017
Email: [email protected]
Telephone: +65 6515 6516
Fax: +65 6515 6513
Registered Office: 2
Corporation Rd #03-04/05
Singapore 618494
Secretary: Peck Jen Jen
Registrar / Transfer Agent: TRICOR BARBINDER SHARE REGISTRATION SERVICES
Registrar Address: 9 Raffles Place, Republic Plaza Tower I #26-01, Singapore 048619
Auditors: RSM SG ASSURANCE LLP
Other Stock Exchange Listings: *SINGAPORE EXCHANGE (CATALIST)
Country: SINGAPORE
Security Type: stocks